BET-inhibition with Apabetalone in Post-ACS Patients with Diabetes: Design and Baseline Characteristics of the BETonMACE trial
2 September 2019 (14:00 - 18:00)
Organised by:
Abstract
About the speaker
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
12 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:00 CET
You may be interested in
Congress Presentation
Congress Presentation
